Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-34a-5p BIRC3 1.9 0 -1.15 0.00716 miRNAWalker2 validate -0.22 0.0078 NA
2 hsa-miR-651-5p BIRC3 2.33 0 -1.15 0.00716 MirTarget -0.41 0 NA
3 hsa-miR-664a-3p BIRC3 0.63 0.0052 -1.15 0.00716 mirMAP -0.3 0.00101 NA
4 hsa-miR-98-5p BIRC3 1.11 0 -1.15 0.00716 miRNAWalker2 validate -0.73 0 NA
5 hsa-miR-326 CARD6 0.72 0.06103 -0.14 0.60161 miRanda -0.13 0.00021 NA
6 hsa-miR-23a-3p CARD8 1 0 -0.15 0.29159 MirTarget -0.15 4.0E-5 NA
7 hsa-miR-324-5p CASP1 2.96 0 -0.39 0.33513 miRanda -0.27 0 NA
8 hsa-miR-361-5p CASP1 0.97 0 -0.39 0.33513 miRanda -0.55 0 NA
9 hsa-miR-421 CASP1 1.18 1.0E-5 -0.39 0.33513 miRanda -0.35 0 NA
10 hsa-miR-429 CASP1 4.49 0 -0.39 0.33513 miRanda -0.24 0 NA
11 hsa-let-7a-5p CASP5 0.62 3.0E-5 0.89 0.08562 TargetScan -0.37 0.03097 NA
12 hsa-miR-139-5p CASP5 -1.53 0 0.89 0.08562 miRanda -0.2 0.02854 NA
13 hsa-miR-335-3p CASP5 3.09 0 0.89 0.08562 mirMAP -0.17 0.00153 NA
14 hsa-miR-2110 CCL2 1.17 6.0E-5 -2.7 0 MirTarget -0.36 1.0E-5 NA
15 hsa-miR-24-3p CCL2 1 0 -2.7 0 miRNAWalker2 validate -0.39 0.00069 NA
16 hsa-miR-26b-5p CCL2 0.89 0 -2.7 0 miRNAWalker2 validate -0.46 6.0E-5 NA
17 hsa-miR-421 CCL2 1.18 1.0E-5 -2.7 0 miRanda -0.3 0.00026 NA
18 hsa-miR-664a-3p CCL2 0.63 0.0052 -2.7 0 MirTarget -0.42 1.0E-5 NA
19 hsa-miR-125a-5p CCL5 0.6 0.01023 -0.09 0.86108 miRNAWalker2 validate -0.27 0.0115 NA
20 hsa-miR-33a-5p CCL5 3.8 0 -0.09 0.86108 MirTarget -0.27 1.0E-5 NA
21 hsa-miR-98-5p CCL5 1.11 0 -0.09 0.86108 miRNAWalker2 validate -0.62 0 NA
22 hsa-miR-29b-2-5p CHUK 0.91 0.00667 -0.12 0.30272 MirTarget -0.11 0 NA
23 hsa-miR-497-5p CHUK 0.03 0.91815 -0.12 0.30272 MirTarget -0.13 0 NA
24 hsa-miR-192-5p CXCL2 2.69 0 -2.99 0 MirTarget -0.35 3.0E-5 NA
25 hsa-miR-215-5p CXCL2 2.31 0 -2.99 0 MirTarget -0.18 0.0021 NA
26 hsa-miR-335-5p CXCL2 1.77 0 -2.99 0 miRNAWalker2 validate -0.31 4.0E-5 NA
27 hsa-miR-532-5p CXCL2 1.56 0 -2.99 0 MirTarget; PITA; miRNATAP -0.4 0.00109 NA
28 hsa-miR-582-5p CXCL2 0.61 0.03299 -2.99 0 MirTarget -0.31 0.00209 NA
29 hsa-miR-7-1-3p CXCL2 1.85 0 -2.99 0 MirTarget -0.26 0.02098 NA
30 hsa-miR-98-5p CXCL2 1.11 0 -2.99 0 miRNAWalker2 validate -0.96 0 NA
31 hsa-miR-30c-5p HSP90AA1 0.78 0.00029 0.24 0.1021 miRNAWalker2 validate -0.11 0.00073 NA
32 hsa-miR-146b-5p IKBKB 1.76 0 -0 0.98871 miRanda -0.12 0 NA
33 hsa-miR-129-5p IL18 -0.52 0.22258 -0.21 0.53621 miRanda -0.12 0.00281 NA
34 hsa-miR-23b-3p IL18 -0.25 0.1502 -0.21 0.53621 MirTarget -0.26 0.0077 NA
35 hsa-miR-30d-3p IL1B 0.98 4.0E-5 0.04 0.94266 MirTarget -0.35 0.00143 NA
36 hsa-let-7a-5p IL6 0.62 3.0E-5 -4.51 0 miRNAWalker2 validate -1.5 0 21352471; 23977098 Knocking down IL-6 and Twist in HSCs significantly reduced let-7 and miR-181 expression and subsequently inhibited chemoresistance and cell invasion;Loss of let 7 microRNA upregulates IL 6 in bone marrow derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer; We also found that IL-6 is a direct target gene for the let-7 microRNA which was downregulated in cancer-associated MSCs; The overexpression of let-7 via the transfection of let-7 precursors decreased IL-6 expression and repressed the adipogenic potential and metastasis-promoting activity of cancer-associated MSCs which was consistent with the inhibition of IL-6 3'UTR luciferase activity; Conversely the treatment of normal MSCs with let-7 inhibitors resulted in effects similar to those seen with IL-6; Taken together our data demonstrated that MSCs co-evolve with prostate cancer cells in the tumor microenvironment and the downregulation of let-7 by cancer-associated MSCs upregulates IL-6 expression
37 hsa-miR-107 IL6 1.31 0 -4.51 0 miRanda -1.33 0 NA
38 hsa-miR-335-5p IL6 1.77 0 -4.51 0 miRNAWalker2 validate -0.47 0 NA
39 hsa-miR-361-5p IL6 0.97 0 -4.51 0 miRanda -1.82 0 NA
40 hsa-miR-429 IL6 4.49 0 -4.51 0 miRanda -0.67 0 NA
41 hsa-miR-98-5p IL6 1.11 0 -4.51 0 miRNAWalker2 validate -1.23 0 25277211 miR 98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL 6; We also found that IL-6 is a target gene of miR-98 and IL-6 represses miR-98 levels via the Stat3-NF-κB-lin28B pathway
42 hsa-miR-140-3p MAPK1 0.06 0.72772 -0.3 0.02025 PITA; miRNATAP -0.13 0.00046 NA
43 hsa-miR-30c-5p MAPK1 0.78 0.00029 -0.3 0.02025 mirMAP -0.16 0 NA
44 hsa-miR-30e-5p MAPK1 1.24 0 -0.3 0.02025 mirMAP -0.12 4.0E-5 NA
45 hsa-miR-34a-5p MAPK1 1.9 0 -0.3 0.02025 mirMAP -0.11 0 NA
46 hsa-miR-130a-3p MAPK10 2.02 0 -1.4 0.00097 miRNATAP -0.43 0 NA
47 hsa-miR-130b-3p MAPK10 3.54 0 -1.4 0.00097 miRNATAP -0.16 0.00796 NA
48 hsa-miR-146b-5p MAPK10 1.76 0 -1.4 0.00097 miRanda -0.59 0 NA
49 hsa-miR-193a-3p MAPK10 1.6 0 -1.4 0.00097 miRanda; miRNATAP -0.42 0 NA
50 hsa-miR-19a-3p MAPK10 3.42 0 -1.4 0.00097 miRNATAP -0.25 5.0E-5 NA
51 hsa-miR-19b-3p MAPK10 2.5 0 -1.4 0.00097 miRNATAP -0.23 0.00332 NA
52 hsa-miR-221-3p MAPK10 0.45 0.09098 -1.4 0.00097 miRNATAP -0.4 0 NA
53 hsa-miR-222-3p MAPK10 0.85 0.00267 -1.4 0.00097 miRNATAP -0.44 0 NA
54 hsa-miR-29a-3p MAPK10 -0.35 0.16124 -1.4 0.00097 miRNATAP -0.45 0 NA
55 hsa-miR-450b-5p MAPK10 1.69 0 -1.4 0.00097 mirMAP -0.2 0.01043 NA
56 hsa-miR-454-3p MAPK10 2.47 0 -1.4 0.00097 miRNATAP -0.21 0.00735 NA
57 hsa-miR-455-5p MAPK10 2.26 0 -1.4 0.00097 miRanda -0.32 0 NA
58 hsa-miR-590-3p MAPK10 2.59 0 -1.4 0.00097 miRanda; mirMAP -0.32 2.0E-5 NA
59 hsa-miR-590-5p MAPK10 3.18 0 -1.4 0.00097 PITA; miRanda; miRNATAP -0.24 0.00024 NA
60 hsa-let-7a-5p MAPK11 0.62 3.0E-5 -0.2 0.44833 miRNAWalker2 validate -0.31 0.00034 NA
61 hsa-miR-125a-5p MAPK12 0.6 0.01023 0.28 0.33766 miRNATAP -0.21 0.00044 NA
62 hsa-miR-125a-5p MAPK14 0.6 0.01023 -0.3 0.00979 PITA; miRanda; miRNATAP -0.12 0 NA
63 hsa-miR-128-3p MAPK14 1.64 0 -0.3 0.00979 MirTarget -0.12 0 NA
64 hsa-miR-185-5p MAPK14 2.34 0 -0.3 0.00979 miRNATAP -0.1 3.0E-5 NA
65 hsa-miR-186-5p MAPK14 1.47 0 -0.3 0.00979 mirMAP -0.15 0 NA
66 hsa-miR-320a MAPK14 0.44 0.03902 -0.3 0.00979 PITA; miRanda -0.14 0 NA
67 hsa-miR-361-5p MAPK14 0.97 0 -0.3 0.00979 miRanda -0.12 0.00025 NA
68 hsa-miR-125a-5p MAPK8 0.6 0.01023 -0.08 0.76049 miRNAWalker2 validate -0.2 7.0E-5 NA
69 hsa-miR-140-3p MAPK8 0.06 0.72772 -0.08 0.76049 miRNAWalker2 validate -0.14 0.03794 NA
70 hsa-miR-195-3p MAPK8 -0.66 0.01421 -0.08 0.76049 mirMAP -0.13 0.00597 NA
71 hsa-miR-22-5p MAPK8 1.88 0 -0.08 0.76049 mirMAP -0.12 0.01477 NA
72 hsa-miR-30b-5p MAPK8 0.8 0.00013 -0.08 0.76049 mirMAP -0.14 0.01802 NA
73 hsa-miR-30c-5p MAPK8 0.78 0.00029 -0.08 0.76049 mirMAP -0.23 3.0E-5 NA
74 hsa-miR-30e-5p MAPK8 1.24 0 -0.08 0.76049 mirMAP -0.15 0.00886 NA
75 hsa-miR-361-5p MAPK9 0.97 0 -0.27 0.00867 miRanda -0.12 4.0E-5 NA
76 hsa-miR-30b-3p MEFV 0.83 0.00097 -0.7 0.14195 MirTarget -0.65 0 NA
77 hsa-miR-940 MEFV 3.21 0 -0.7 0.14195 MirTarget -0.33 0 NA
78 hsa-miR-331-5p NAIP 2.17 0 -0.15 0.58714 MirTarget -0.16 0.00279 NA
79 hsa-miR-7-1-3p NAIP 1.85 0 -0.15 0.58714 mirMAP -0.12 0.02485 NA
80 hsa-miR-450b-5p NFKB1 1.69 0 -0.65 5.0E-5 MirTarget; PITA -0.12 1.0E-5 NA
81 hsa-miR-92a-3p NFKB1 2.06 0 -0.65 5.0E-5 miRNAWalker2 validate -0.15 1.0E-5 NA
82 hsa-miR-335-5p NLRC4 1.77 0 -0.1 0.7189 miRNAWalker2 validate -0.11 0.00065 NA
83 hsa-miR-324-5p NLRP1 2.96 0 -0.97 0.00192 miRNATAP -0.2 2.0E-5 NA
84 hsa-miR-335-5p NLRP1 1.77 0 -0.97 0.00192 miRNAWalker2 validate -0.13 0.00086 NA
85 hsa-miR-590-3p NLRP1 2.59 0 -0.97 0.00192 miRanda; mirMAP -0.16 0.00415 NA
86 hsa-miR-28-5p NLRP3 0.23 0.07429 -1.77 2.0E-5 miRanda -0.51 0.00161 NA
87 hsa-miR-320a NLRP3 0.44 0.03902 -1.77 2.0E-5 miRanda -0.54 0 NA
88 hsa-miR-320b NLRP3 1.56 0 -1.77 2.0E-5 miRanda -0.45 0 NA
89 hsa-miR-324-5p NLRP3 2.96 0 -1.77 2.0E-5 miRanda -0.41 0 NA
90 hsa-miR-421 NLRP3 1.18 1.0E-5 -1.77 2.0E-5 miRanda -0.44 0 NA
91 hsa-miR-429 NLRP3 4.49 0 -1.77 2.0E-5 miRanda -0.46 0 NA
92 hsa-miR-589-3p NLRP3 2.52 0 -1.77 2.0E-5 MirTarget -0.18 0.00223 NA
93 hsa-miR-107 NOD1 1.31 0 0.03 0.86343 miRanda -0.15 3.0E-5 NA
94 hsa-miR-192-5p NOD2 2.69 0 0.14 0.73611 miRNAWalker2 validate; MirTarget -0.16 0.00787 NA
95 hsa-miR-215-5p NOD2 2.31 0 0.14 0.73611 miRNAWalker2 validate; MirTarget -0.16 0.00012 NA
96 hsa-miR-320a NOD2 0.44 0.03902 0.14 0.73611 miRanda -0.46 0 NA
97 hsa-miR-33a-3p NOD2 1.73 0 0.14 0.73611 MirTarget -0.24 0.0004 NA
98 hsa-miR-421 NOD2 1.18 1.0E-5 0.14 0.73611 miRanda -0.21 0.00893 NA
99 hsa-miR-940 NOD2 3.21 0 0.14 0.73611 MirTarget -0.23 1.0E-5 NA
100 hsa-miR-28-5p SUGT1 0.23 0.07429 0.22 0.07785 miRanda -0.13 0.00529 NA
101 hsa-miR-203a-3p TNF 3.12 0 0.17 0.71172 miRTarBase -0.11 0.00098 NA
102 hsa-miR-320a TNF 0.44 0.03902 0.17 0.71172 miRanda -0.39 0.00015 NA
103 hsa-miR-361-5p TNF 0.97 0 0.17 0.71172 miRanda -0.36 0.00589 NA
104 hsa-miR-429 TNF 4.49 0 0.17 0.71172 miRNATAP -0.17 2.0E-5 NA
105 hsa-let-7a-5p TNFAIP3 0.62 3.0E-5 -1.63 0 TargetScan; miRNATAP -0.42 0.00022 NA
106 hsa-let-7b-5p TNFAIP3 0.6 0.0014 -1.63 0 miRNATAP -0.18 0.04103 NA
107 hsa-let-7d-5p TNFAIP3 1.33 0 -1.63 0 miRNATAP -0.45 0 NA
108 hsa-let-7e-5p TNFAIP3 0.86 6.0E-5 -1.63 0 miRNATAP -0.33 2.0E-5 NA
109 hsa-let-7f-5p TNFAIP3 0.5 0.00356 -1.63 0 miRNATAP -0.33 0.00069 NA
110 hsa-let-7g-5p TNFAIP3 1.2 0 -1.63 0 miRNATAP -0.51 0 NA
111 hsa-miR-107 TNFAIP3 1.31 0 -1.63 0 miRanda; miRNATAP -0.33 0.0001 NA
112 hsa-miR-125a-5p TNFAIP3 0.6 0.01023 -1.63 0 miRNAWalker2 validate; miRTarBase; miRanda -0.31 1.0E-5 NA
113 hsa-miR-141-3p TNFAIP3 5.02 0 -1.63 0 TargetScan -0.22 0 NA
114 hsa-miR-19a-3p TNFAIP3 3.42 0 -1.63 0 miRNATAP -0.17 0.00084 NA
115 hsa-miR-19b-3p TNFAIP3 2.5 0 -1.63 0 miRNATAP -0.25 9.0E-5 NA
116 hsa-miR-23b-3p TNFAIP3 -0.25 0.1502 -1.63 0 miRNATAP -0.34 0.00035 NA
117 hsa-miR-26b-5p TNFAIP3 0.89 0 -1.63 0 miRNAWalker2 validate -0.18 0.04358 NA
118 hsa-miR-27b-5p TNFAIP3 0.39 0.0517 -1.63 0 miRNATAP -0.2 0.01609 NA
119 hsa-miR-330-3p TNFAIP3 0.88 0.00074 -1.63 0 miRNATAP -0.25 6.0E-5 NA
120 hsa-miR-429 TNFAIP3 4.49 0 -1.63 0 miRanda -0.25 0 NA
121 hsa-miR-125b-5p XIAP -1.16 0.00029 0.02 0.90046 miRNAWalker2 validate -0.13 0 NA
122 hsa-miR-146b-5p XIAP 1.76 0 0.02 0.90046 mirMAP; miRNATAP -0.1 0 NA
123 hsa-miR-195-3p XIAP -0.66 0.01421 0.02 0.90046 mirMAP -0.11 5.0E-5 NA
124 hsa-miR-26a-2-3p XIAP 0.82 0.00017 0.02 0.90046 mirMAP -0.1 0.0017 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 RESPONSE TO BACTERIUM 21 528 1.275e-25 5.932e-22
2 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 18 321 2.586e-24 6.016e-21
3 REGULATION OF INFLAMMATORY RESPONSE 17 294 4.15e-23 6.436e-20
4 RESPONSE TO BIOTIC STIMULUS 22 886 1.573e-22 1.83e-19
5 REGULATION OF DEFENSE RESPONSE 21 759 2.569e-22 2.196e-19
6 REGULATION OF RESPONSE TO STRESS 25 1468 2.832e-22 2.196e-19
7 REGULATION OF CYTOKINE PRODUCTION 19 563 1.46e-21 9.704e-19
8 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 17 365 1.706e-21 9.92e-19
9 REGULATION OF IMMUNE SYSTEM PROCESS 24 1403 3.492e-21 1.805e-18
10 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 17 404 9.648e-21 4.489e-18
11 REGULATION OF RESPONSE TO WOUNDING 17 413 1.404e-20 5.753e-18
12 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 24 1492 1.484e-20 5.753e-18
13 INFLAMMATORY RESPONSE 17 454 7.01e-20 2.509e-17
14 POSITIVE REGULATION OF CYTOKINE PRODUCTION 16 370 1.195e-19 3.972e-17
15 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 20 867 1.492e-19 4.627e-17
16 POSITIVE REGULATION OF RESPONSE TO STIMULUS 25 1929 2.264e-19 6.197e-17
17 CELLULAR RESPONSE TO BIOTIC STIMULUS 13 163 2.143e-19 6.197e-17
18 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 20 926 5.434e-19 1.405e-16
19 POSITIVE REGULATION OF MOLECULAR FUNCTION 24 1791 1.066e-18 2.611e-16
20 CELL DEATH 20 1001 2.496e-18 5.807e-16
21 REGULATION OF IMMUNE RESPONSE 19 858 3.972e-18 8.8e-16
22 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 13 213 7.451e-18 1.576e-15
23 REGULATION OF CELL DEATH 22 1472 8.934e-18 1.807e-15
24 RESPONSE TO EXTERNAL STIMULUS 23 1821 3.83e-17 7.426e-15
25 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 9 48 4.403e-17 8.195e-15
26 RESPONSE TO OXYGEN CONTAINING COMPOUND 21 1381 5.764e-17 1.031e-14
27 RESPONSE TO LIPID 18 888 2.101e-16 3.492e-14
28 POSITIVE REGULATION OF DEFENSE RESPONSE 14 364 2.043e-16 3.492e-14
29 REGULATION OF INTERLEUKIN 1 PRODUCTION 9 58 2.765e-16 4.437e-14
30 POSITIVE REGULATION OF CYTOKINE SECRETION 10 96 3.389e-16 5.256e-14
31 REGULATION OF CYTOKINE SECRETION 11 149 4.537e-16 6.81e-14
32 REGULATION OF PEPTIDASE ACTIVITY 14 392 5.726e-16 8.326e-14
33 PROTEIN PHOSPHORYLATION 18 944 6.124e-16 8.634e-14
34 STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 10 103 7.035e-16 9.628e-14
35 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 15 514 7.807e-16 1.038e-13
36 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 12 233 1.345e-15 1.738e-13
37 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 20 1395 1.554e-15 1.954e-13
38 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 21 1656 2.261e-15 2.769e-13
39 POSITIVE REGULATION OF IMMUNE RESPONSE 15 563 2.986e-15 3.563e-13
40 IMMUNE SYSTEM PROCESS 22 1984 4.936e-15 5.742e-13
41 POSITIVE REGULATION OF CATALYTIC ACTIVITY 20 1518 7.848e-15 8.906e-13
42 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 10 132 9.027e-15 1e-12
43 POSITIVE REGULATION OF CELL COMMUNICATION 20 1532 9.352e-15 1.012e-12
44 POSITIVE REGULATION OF TRANSPORT 17 936 1.237e-14 1.308e-12
45 POSITIVE REGULATION OF PROTEIN SECRETION 11 211 2.191e-14 2.265e-12
46 POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 7 30 3.339e-14 3.378e-12
47 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 10 154 4.336e-14 4.203e-12
48 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 7 31 4.309e-14 4.203e-12
49 PHOSPHORYLATION 18 1228 5.852e-14 5.557e-12
50 DEFENSE RESPONSE 18 1231 6.103e-14 5.679e-12
51 RESPONSE TO NITROGEN COMPOUND 16 859 6.873e-14 6.27e-12
52 REGULATION OF PROTEOLYSIS 15 711 9.054e-14 8.102e-12
53 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 16 876 9.297e-14 8.162e-12
54 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 7 36 1.36e-13 1.172e-11
55 CELLULAR RESPONSE TO LIPID 13 457 1.478e-13 1.251e-11
56 IMMUNE RESPONSE 17 1100 1.727e-13 1.435e-11
57 REGULATION OF HYDROLASE ACTIVITY 18 1327 2.213e-13 1.807e-11
58 INTRACELLULAR SIGNAL TRANSDUCTION 19 1572 2.61e-13 2.094e-11
59 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 20 1848 3.288e-13 2.55e-11
60 REGULATION OF PROTEIN LOCALIZATION 16 950 3.234e-13 2.55e-11
61 POSITIVE REGULATION OF SECRETION 12 370 3.367e-13 2.568e-11
62 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 15 799 4.907e-13 3.683e-11
63 REGULATION OF PROTEIN SECRETION 12 389 6.081e-13 4.491e-11
64 REGULATION OF PROTEIN MODIFICATION PROCESS 19 1710 1.179e-12 8.575e-11
65 POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION 6 24 1.644e-12 1.177e-10
66 REGULATION OF CELLULAR LOCALIZATION 17 1277 1.928e-12 1.359e-10
67 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 10 228 2.239e-12 1.555e-10
68 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 8 95 2.416e-12 1.653e-10
69 REGULATION OF TRANSPORT 19 1804 3.062e-12 2.065e-10
70 POSITIVE REGULATION OF CELL DEATH 13 605 5.141e-12 3.417e-10
71 POSITIVE REGULATION OF PROTEOLYSIS 11 363 8.199e-12 5.373e-10
72 ZYMOGEN ACTIVATION 8 112 9.273e-12 5.993e-10
73 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 9 179 9.652e-12 6.152e-10
74 REGULATION OF INTERLEUKIN 1 SECRETION 6 33 1.339e-11 8.417e-10
75 RESPONSE TO ENDOGENOUS STIMULUS 17 1450 1.473e-11 9.138e-10
76 RESPONSE TO PEPTIDE 11 404 2.592e-11 1.587e-09
77 RESPONSE TO MURAMYL DIPEPTIDE 5 15 2.643e-11 1.597e-09
78 NEGATIVE REGULATION OF CELL DEATH 14 872 3.058e-11 1.824e-09
79 REGULATION OF SECRETION 13 699 3.126e-11 1.841e-09
80 RESPONSE TO CYTOKINE 13 714 4.071e-11 2.339e-09
81 RESPONSE TO MECHANICAL STIMULUS 9 210 4.051e-11 2.339e-09
82 ACTIVATION OF MAPK ACTIVITY 8 137 4.74e-11 2.69e-09
83 CELLULAR RESPONSE TO STRESS 17 1565 4.946e-11 2.773e-09
84 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 15 1135 7.345e-11 4.069e-09
85 RESPONSE TO TUMOR NECROSIS FACTOR 9 233 1.024e-10 5.607e-09
86 CELLULAR RESPONSE TO CYTOKINE STIMULUS 12 606 1.066e-10 5.768e-09
87 POSITIVE REGULATION OF MAPK CASCADE 11 470 1.305e-10 6.977e-09
88 INNATE IMMUNE RESPONSE 12 619 1.361e-10 7.195e-09
89 RESPONSE TO TOXIC SUBSTANCE 9 241 1.383e-10 7.231e-09
90 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 9 246 1.66e-10 8.582e-09
91 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 18 1977 1.825e-10 9.33e-09
92 REGULATION OF INNATE IMMUNE RESPONSE 10 357 1.861e-10 9.414e-09
93 POSITIVE REGULATION OF GENE EXPRESSION 17 1733 2.461e-10 1.232e-08
94 REGULATION OF MAPK CASCADE 12 660 2.839e-10 1.406e-08
95 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 7 113 5.763e-10 2.823e-08
96 POSITIVE REGULATION OF HYDROLASE ACTIVITY 13 905 7.559e-10 3.664e-08
97 NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 5 28 8.519e-10 4.047e-08
98 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 9 296 8.523e-10 4.047e-08
99 CYTOKINE PRODUCTION 7 120 8.806e-10 4.139e-08
100 ACTIVATION OF IMMUNE RESPONSE 10 427 1.057e-09 4.921e-08
101 ACTIVATION OF INNATE IMMUNE RESPONSE 8 204 1.139e-09 5.248e-08
102 FC RECEPTOR SIGNALING PATHWAY 8 206 1.231e-09 5.614e-08
103 POSITIVE REGULATION OF MAP KINASE ACTIVITY 8 207 1.279e-09 5.776e-08
104 CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 5 33 2.045e-09 9.151e-08
105 FC EPSILON RECEPTOR SIGNALING PATHWAY 7 142 2.869e-09 1.272e-07
106 RESPONSE TO ABIOTIC STIMULUS 13 1024 3.391e-09 1.488e-07
107 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 13 1036 3.903e-09 1.681e-07
108 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 13 1036 3.903e-09 1.681e-07
109 JNK CASCADE 6 82 3.998e-09 1.707e-07
110 POSITIVE REGULATION OF CELL CELL ADHESION 8 243 4.521e-09 1.912e-07
111 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 16 1805 4.781e-09 2.004e-07
112 RESPONSE TO VIRUS 8 247 5.139e-09 2.135e-07
113 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 6 86 5.343e-09 2.2e-07
114 CELLULAR RESPONSE TO INTERLEUKIN 1 6 88 6.145e-09 2.508e-07
115 NEGATIVE REGULATION OF MOLECULAR FUNCTION 13 1079 6.37e-09 2.577e-07
116 REGULATION OF OXIDOREDUCTASE ACTIVITY 6 90 7.043e-09 2.825e-07
117 POSITIVE REGULATION OF RESPONSE TO WOUNDING 7 162 7.188e-09 2.859e-07
118 POSITIVE REGULATION OF HEMOPOIESIS 7 163 7.502e-09 2.958e-07
119 INTERLEUKIN 1 PRODUCTION 4 15 8.275e-09 3.235e-07
120 PROTEIN MATURATION 8 265 8.91e-09 3.455e-07
121 REGULATION OF PHOSPHORUS METABOLIC PROCESS 15 1618 9.989e-09 3.841e-07
122 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 172 1.089e-08 4.154e-07
123 ACTIVATION OF PROTEIN KINASE ACTIVITY 8 279 1.331e-08 5.036e-07
124 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 5 48 1.45e-08 5.441e-07
125 REGULATION OF PROTEIN IMPORT 7 183 1.673e-08 6.188e-07
126 POSITIVE REGULATION OF PROTEIN IMPORT 6 104 1.689e-08 6.188e-07
127 REGULATION OF INTERLEUKIN 6 PRODUCTION 6 104 1.689e-08 6.188e-07
128 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 8 289 1.751e-08 6.366e-07
129 REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 5 50 1.79e-08 6.457e-07
130 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 6 109 2.241e-08 7.959e-07
131 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 6 109 2.241e-08 7.959e-07
132 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 5 53 2.416e-08 8.516e-07
133 REGULATION OF KINASE ACTIVITY 11 776 2.476e-08 8.663e-07
134 RESPONSE TO AMINO ACID 6 112 2.638e-08 9.161e-07
135 REGULATION OF PROTEIN TARGETING 8 307 2.799e-08 9.647e-07
136 RESPONSE TO INTERLEUKIN 1 6 115 3.092e-08 1.058e-06
137 REGULATION OF CELL PROLIFERATION 14 1496 3.413e-08 1.159e-06
138 RESPONSE TO ACID CHEMICAL 8 319 3.766e-08 1.252e-06
139 REGULATION OF MAP KINASE ACTIVITY 8 319 3.766e-08 1.252e-06
140 REGULATION OF INTRACELLULAR TRANSPORT 10 621 3.763e-08 1.252e-06
141 POSITIVE REGULATION OF CELL PROLIFERATION 11 814 4.04e-08 1.333e-06
142 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 8 323 4.146e-08 1.359e-06
143 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 6 121 4.194e-08 1.365e-06
144 POSITIVE REGULATION OF CELL DIFFERENTIATION 11 823 4.521e-08 1.461e-06
145 REGULATION OF MONOOXYGENASE ACTIVITY 5 60 4.561e-08 1.463e-06
146 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 9 470 4.731e-08 1.508e-06
147 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 7 218 5.574e-08 1.764e-06
148 POSITIVE REGULATION OF KINASE ACTIVITY 9 482 5.87e-08 1.845e-06
149 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 7 220 5.934e-08 1.853e-06
150 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 6 129 6.15e-08 1.908e-06
151 REGULATION OF CHEMOKINE PRODUCTION 5 65 6.857e-08 2.099e-06
152 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 5 65 6.857e-08 2.099e-06
153 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 5 68 8.624e-08 2.623e-06
154 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 8 360 9.558e-08 2.888e-06
155 I KAPPAB KINASE NF KAPPAB SIGNALING 5 70 9.989e-08 2.999e-06
156 REGULATION OF ERK1 AND ERK2 CASCADE 7 238 1.016e-07 3.029e-06
157 DETECTION OF BIOTIC STIMULUS 4 27 1.049e-07 3.109e-06
158 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 8 370 1.179e-07 3.465e-06
159 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 6 144 1.184e-07 3.465e-06
160 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 4 28 1.223e-07 3.555e-06
161 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 74 1.323e-07 3.778e-06
162 REGULATION OF ACUTE INFLAMMATORY RESPONSE 5 74 1.323e-07 3.778e-06
163 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 12 1142 1.314e-07 3.778e-06
164 POSITIVE REGULATION OF CELL ADHESION 8 376 1.334e-07 3.784e-06
165 REGULATION OF LEUKOCYTE MIGRATION 6 149 1.45e-07 4.064e-06
166 REGULATION OF CELL CELL ADHESION 8 380 1.446e-07 4.064e-06
167 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 381 1.476e-07 4.111e-06
168 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 6 152 1.632e-07 4.519e-06
169 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 7 258 1.758e-07 4.841e-06
170 REGULATION OF TRANSFERASE ACTIVITY 11 946 1.856e-07 5.06e-06
171 REGULATION OF CELLULAR PROTEIN LOCALIZATION 9 552 1.859e-07 5.06e-06
172 CELLULAR RESPONSE TO MECHANICAL STIMULUS 5 80 1.961e-07 5.305e-06
173 CELLULAR RESPONSE TO ABIOTIC STIMULUS 7 263 2.003e-07 5.386e-06
174 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 5 81 2.088e-07 5.583e-06
175 PROTEIN KINASE B SIGNALING 4 34 2.75e-07 7.312e-06
176 REGULATION OF CELL DIFFERENTIATION 13 1492 2.928e-07 7.742e-06
177 POSITIVE REGULATION OF LOCOMOTION 8 420 3.101e-07 8.152e-06
178 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 5 88 3.166e-07 8.276e-06
179 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 9 616 4.683e-07 1.217e-05
180 REGULATION OF GRANULOCYTE CHEMOTAXIS 4 39 4.849e-07 1.253e-05
181 REGULATION OF LEUKOCYTE CHEMOTAXIS 5 96 4.894e-07 1.258e-05
182 CYTOKINE MEDIATED SIGNALING PATHWAY 8 452 5.408e-07 1.383e-05
183 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 10 829 5.509e-07 1.401e-05
184 REGULATION OF HOMOTYPIC CELL CELL ADHESION 7 307 5.689e-07 1.439e-05
185 POSITIVE REGULATION OF CELL ACTIVATION 7 311 6.205e-07 1.561e-05
186 REGULATION OF HEMOPOIESIS 7 314 6.618e-07 1.656e-05
187 REGULATION OF FEVER GENERATION 3 11 6.692e-07 1.656e-05
188 REGULATION OF CHRONIC INFLAMMATORY RESPONSE 3 11 6.692e-07 1.656e-05
189 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 6 197 7.511e-07 1.849e-05
190 REGULATION OF CYTOPLASMIC TRANSPORT 8 481 8.64e-07 2.116e-05
191 REGULATION OF VITAMIN METABOLIC PROCESS 3 12 8.913e-07 2.138e-05
192 REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 3 12 8.913e-07 2.138e-05
193 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 3 12 8.913e-07 2.138e-05
194 REGULATION OF ESTABLISHMENT OF ENDOTHELIAL BARRIER 3 12 8.913e-07 2.138e-05
195 REGULATION OF CELL ACTIVATION 8 484 9.053e-07 2.16e-05
196 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 4 47 1.042e-06 2.461e-05
197 RESPONSE TO ANTIBIOTIC 4 47 1.042e-06 2.461e-05
198 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 6 211 1.121e-06 2.635e-05
199 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 4 48 1.135e-06 2.654e-05
200 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 4 49 1.235e-06 2.872e-05
201 CELLULAR RESPONSE TO NITROGEN COMPOUND 8 505 1.245e-06 2.882e-05
202 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 6 216 1.285e-06 2.96e-05
203 RESPONSE TO ORGANIC CYCLIC COMPOUND 10 917 1.381e-06 3.166e-05
204 REGULATION OF INTERLEUKIN 12 PRODUCTION 4 51 1.453e-06 3.314e-05
205 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 14 1.471e-06 3.323e-05
206 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 3 14 1.471e-06 3.323e-05
207 POSITIVE REGULATION OF CHEMOTAXIS 5 120 1.484e-06 3.335e-05
208 REGULATION OF HEAT GENERATION 3 15 1.837e-06 4.071e-05
209 NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 3 15 1.837e-06 4.071e-05
210 CHRONIC INFLAMMATORY RESPONSE 3 15 1.837e-06 4.071e-05
211 PROTEOLYSIS 11 1208 2.101e-06 4.632e-05
212 DEFENSE RESPONSE TO BACTERIUM 6 237 2.202e-06 4.833e-05
213 REGULATION OF MONONUCLEAR CELL MIGRATION 3 16 2.259e-06 4.934e-05
214 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 5 131 2.287e-06 4.973e-05
215 RESPONSE TO ALKALOID 5 137 2.851e-06 6.17e-05
216 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 7 397 3.151e-06 6.789e-05
217 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 3 18 3.284e-06 7.041e-05
218 NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 3 19 3.895e-06 8.201e-05
219 DETECTION OF OTHER ORGANISM 3 19 3.895e-06 8.201e-05
220 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 3 19 3.895e-06 8.201e-05
221 RESPONSE TO SALT STRESS 3 19 3.895e-06 8.201e-05
222 CELLULAR RESPONSE TO EXTERNAL STIMULUS 6 264 4.104e-06 8.602e-05
223 PEPTIDYL SERINE MODIFICATION 5 148 4.164e-06 8.689e-05
224 REGULATION OF MUSCLE CELL DIFFERENTIATION 5 152 4.745e-06 9.856e-05
225 REGULATION OF IMMUNE EFFECTOR PROCESS 7 424 4.859e-06 0.0001005
226 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 5 154 5.058e-06 0.0001041
227 RESPONSE TO DRUG 7 431 5.41e-06 0.0001104
228 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 5 156 5.387e-06 0.0001104
229 PROTEIN OLIGOMERIZATION 7 434 5.661e-06 0.000115
230 REGULATION OF JNK CASCADE 5 159 5.911e-06 0.0001196
231 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 6 282 5.992e-06 0.0001207
232 CELLULAR RESPONSE TO INTERLEUKIN 6 3 22 6.169e-06 0.0001237
233 REGULATION OF CELL ADHESION 8 629 6.337e-06 0.0001261
234 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 10 1087 6.339e-06 0.0001261
235 CELL CHEMOTAXIS 5 162 6.476e-06 0.0001282
236 REGULATION OF HOMEOSTATIC PROCESS 7 447 6.867e-06 0.0001354
237 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 5 168 7.73e-06 0.0001518
238 TAXIS 7 464 8.759e-06 0.0001712
239 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 7 465 8.883e-06 0.0001729
240 PROTEIN COMPLEX BIOGENESIS 10 1132 9.071e-06 0.0001751
241 PROTEIN COMPLEX ASSEMBLY 10 1132 9.071e-06 0.0001751
242 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 4 81 9.342e-06 0.0001796
243 RESPONSE TO CORTICOSTEROID 5 176 9.69e-06 0.0001855
244 RESPONSE TO GROWTH FACTOR 7 475 1.02e-05 0.0001945
245 REGULATION OF TYPE 2 IMMUNE RESPONSE 3 26 1.037e-05 0.0001961
246 RESPONSE TO INTERLEUKIN 6 3 26 1.037e-05 0.0001961
247 REGULATION OF CHEMOTAXIS 5 180 1.081e-05 0.0002036
248 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 4 85 1.132e-05 0.0002123
249 REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 3 27 1.165e-05 0.0002169
250 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 3 27 1.165e-05 0.0002169
251 REGULATION OF CELLULAR RESPONSE TO STRESS 8 691 1.258e-05 0.0002332
252 RESPONSE TO HEAT 4 89 1.358e-05 0.0002508
253 RESPONSE TO STEROID HORMONE 7 497 1.368e-05 0.0002516
254 POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING 3 29 1.452e-05 0.000265
255 POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 3 29 1.452e-05 0.000265
256 DEFENSE RESPONSE TO OTHER ORGANISM 7 505 1.517e-05 0.0002757
257 RESPONSE TO ATP 3 30 1.612e-05 0.0002907
258 MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 3 30 1.612e-05 0.0002907
259 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 4 94 1.687e-05 0.000303
260 POSITIVE REGULATION OF T CELL PROLIFERATION 4 95 1.759e-05 0.0003135
261 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 4 95 1.759e-05 0.0003135
262 SKELETAL MUSCLE CONTRACTION 3 31 1.783e-05 0.0003154
263 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 3 31 1.783e-05 0.0003154
264 REGULATION OF LEUKOCYTE PROLIFERATION 5 206 2.073e-05 0.0003639
265 MYELOID LEUKOCYTE MIGRATION 4 99 2.07e-05 0.0003639
266 RESPONSE TO OXIDATIVE STRESS 6 352 2.111e-05 0.0003693
267 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 4 100 2.154e-05 0.000372
268 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 4 100 2.154e-05 0.000372
269 RESPONSE TO DEXAMETHASONE 3 33 2.159e-05 0.000372
270 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 9 983 2.137e-05 0.000372
271 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 4 101 2.24e-05 0.0003846
272 CELLULAR RESPONSE TO ALKALOID 3 34 2.365e-05 0.0004046
273 REGULATION OF CIRCADIAN RHYTHM 4 103 2.42e-05 0.0004125
274 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 9 1004 2.527e-05 0.0004291
275 NEGATIVE REGULATION OF PROTEIN PROCESSING 3 35 2.584e-05 0.0004356
276 NEGATIVE REGULATION OF PROTEIN MATURATION 3 35 2.584e-05 0.0004356
277 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 9 1008 2.608e-05 0.000438
278 REGULATION OF CELLULAR COMPONENT MOVEMENT 8 771 2.771e-05 0.0004638
279 NEGATIVE REGULATION OF PROTEIN SECRETION 4 108 2.916e-05 0.0004864
280 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 4 111 3.248e-05 0.0005397
281 CYTOKINE SECRETION 3 38 3.319e-05 0.0005496
282 REGULATION OF LEUKOCYTE DIFFERENTIATION 5 232 3.663e-05 0.0006044
283 REGULATION OF VASCULATURE DEVELOPMENT 5 233 3.739e-05 0.0006147
284 LEUKOCYTE CHEMOTAXIS 4 117 3.992e-05 0.0006541
285 REGULATION OF LIPID STORAGE 3 41 4.18e-05 0.0006707
286 MULTICELLULAR ORGANISMAL MOVEMENT 3 41 4.18e-05 0.0006707
287 MITOTIC SPINDLE ASSEMBLY 3 41 4.18e-05 0.0006707
288 MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 3 41 4.18e-05 0.0006707
289 MUSCULOSKELETAL MOVEMENT 3 41 4.18e-05 0.0006707
290 MONOCYTE CHEMOTAXIS 3 41 4.18e-05 0.0006707
291 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 10 1360 4.457e-05 0.0007127
292 REGULATION OF NIK NF KAPPAB SIGNALING 3 42 4.497e-05 0.0007165
293 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 5 245 4.749e-05 0.0007542
294 REGULATION OF ADAPTIVE IMMUNE RESPONSE 4 123 4.855e-05 0.0007684
295 RESPONSE TO RADIATION 6 413 5.163e-05 0.0008143
296 REGULATION OF NEURON DEATH 5 252 5.429e-05 0.0008534
297 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 3 45 5.539e-05 0.0008649
298 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 3 45 5.539e-05 0.0008649
299 REGULATION OF LIPID BIOSYNTHETIC PROCESS 4 128 5.672e-05 0.0008768
300 MACROMOLECULAR COMPLEX ASSEMBLY 10 1398 5.636e-05 0.0008768
301 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 4 128 5.672e-05 0.0008768
302 LOCOMOTION 9 1114 5.715e-05 0.0008805
303 REGULATION OF PEPTIDE TRANSPORT 5 256 5.85e-05 0.0008983
304 POSITIVE REGULATION OF PHAGOCYTOSIS 3 46 5.919e-05 0.000903
305 NEGATIVE REGULATION OF CYTOKINE SECRETION 3 46 5.919e-05 0.000903
306 LEUKOCYTE MIGRATION 5 259 6.182e-05 0.00094
307 REGULATION OF MYOBLAST DIFFERENTIATION 3 48 6.729e-05 0.00102
308 AGING 5 264 6.767e-05 0.001022
309 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 4 135 6.979e-05 0.001051
310 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 4 136 7.182e-05 0.001071
311 REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 3 49 7.16e-05 0.001071
312 REGULATION OF STEROID BIOSYNTHETIC PROCESS 3 49 7.16e-05 0.001071
313 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 9 1152 7.414e-05 0.001102
314 RESPONSE TO HORMONE 8 893 7.849e-05 0.001163
315 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 3 51 8.075e-05 0.001178
316 NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 3 51 8.075e-05 0.001178
317 CELLULAR RESPONSE TO PEPTIDE 5 274 8.066e-05 0.001178
318 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 3 51 8.075e-05 0.001178
319 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 5 274 8.066e-05 0.001178
320 REGULATION OF JAK STAT CASCADE 4 144 8.966e-05 0.001292
321 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 5 280 8.933e-05 0.001292
322 NEGATIVE REGULATION OF DEFENSE RESPONSE 4 144 8.966e-05 0.001292
323 REGULATION OF STAT CASCADE 4 144 8.966e-05 0.001292
324 REGULATION OF LIPID METABOLIC PROCESS 5 282 9.238e-05 0.001327
325 T CELL RECEPTOR SIGNALING PATHWAY 4 146 9.458e-05 0.001354
326 REGULATION OF EPITHELIAL CELL PROLIFERATION 5 285 9.709e-05 0.001382
327 REGULATION OF T CELL PROLIFERATION 4 147 9.712e-05 0.001382
328 RESPONSE TO TEMPERATURE STIMULUS 4 148 9.97e-05 0.001414
329 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 3 57 0.0001127 0.001594
330 PROTEIN COMPLEX SUBUNIT ORGANIZATION 10 1527 0.0001185 0.001671
331 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 4 156 0.0001222 0.001712
332 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 4 156 0.0001222 0.001712
333 RESPONSE TO PURINE CONTAINING COMPOUND 4 158 0.0001283 0.001793
334 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 3 60 0.0001314 0.00183
335 REGULATION OF INTERLEUKIN 8 PRODUCTION 3 61 0.000138 0.001917
336 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 2 11 0.0001439 0.001986
337 POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 2 11 0.0001439 0.001986
338 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 6 498 0.0001446 0.001991
339 RESPONSE TO OSMOTIC STRESS 3 63 0.0001519 0.002085
340 REGULATION OF CATABOLIC PROCESS 7 731 0.0001576 0.002157
341 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 9 1275 0.0001613 0.002202
342 POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION 3 65 0.0001667 0.002268
343 NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY 4 170 0.0001701 0.002307
344 I KAPPAB PHOSPHORYLATION 2 12 0.0001725 0.002333
345 NEGATIVE REGULATION OF NEURON DEATH 4 171 0.000174 0.002346
346 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 3 66 0.0001745 0.002346
347 NEGATIVE REGULATION OF PROTEOLYSIS 5 329 0.0001899 0.002527
348 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 3 68 0.0001906 0.002527
349 REGULATION OF ALPHA BETA T CELL ACTIVATION 3 68 0.0001906 0.002527
350 CELLULAR RESPONSE TO ACID CHEMICAL 4 175 0.0001901 0.002527
351 REGULATION OF PHAGOCYTOSIS 3 68 0.0001906 0.002527
352 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 3 69 0.0001991 0.002617
353 MITOTIC SPINDLE ORGANIZATION 3 69 0.0001991 0.002617
354 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 8 1021 0.0001988 0.002617
355 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 2 13 0.0002036 0.002624
356 REGULATION OF PROSTAGLANDIN SECRETION 2 13 0.0002036 0.002624
357 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 2 13 0.0002036 0.002624
358 POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 2 13 0.0002036 0.002624
359 MACROPHAGE CHEMOTAXIS 2 13 0.0002036 0.002624
360 POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 2 13 0.0002036 0.002624
361 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 2 13 0.0002036 0.002624
362 SPINDLE ASSEMBLY 3 70 0.0002078 0.002671
363 RESPONSE TO KETONE 4 182 0.0002209 0.002831
364 REGULATION OF MYELOID CELL DIFFERENTIATION 4 183 0.0002255 0.002871
365 CHEMOKINE MEDIATED SIGNALING PATHWAY 3 72 0.0002259 0.002871
366 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 3 72 0.0002259 0.002871
367 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 3 73 0.0002353 0.002959
368 POSITIVE REGULATION OF STAT CASCADE 3 73 0.0002353 0.002959
369 CELLULAR RESPONSE TO KETONE 3 73 0.0002353 0.002959
370 POSITIVE REGULATION OF JAK STAT CASCADE 3 73 0.0002353 0.002959
371 REGULATION OF PODOSOME ASSEMBLY 2 14 0.0002373 0.002968
372 NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 2 14 0.0002373 0.002968
373 REGULATION OF STEROID METABOLIC PROCESS 3 74 0.0002449 0.003056
374 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 10 1672 0.0002506 0.003118
375 GRANULOCYTE MIGRATION 3 75 0.0002549 0.003162
376 NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 2 15 0.0002735 0.003332
377 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 2 15 0.0002735 0.003332
378 REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 2 15 0.0002735 0.003332
379 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 2 15 0.0002735 0.003332
380 RESPONSE TO HYDROPEROXIDE 2 15 0.0002735 0.003332
381 POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 2 15 0.0002735 0.003332
382 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 2 15 0.0002735 0.003332
383 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 7 801 0.0002763 0.003357
384 RESPONSE TO WOUNDING 6 563 0.0002808 0.003402
385 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 4 195 0.0002874 0.003473
386 ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 5 361 0.0002918 0.003518
387 REGULATION OF APOPTOTIC SIGNALING PATHWAY 5 363 0.0002993 0.003599
388 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 3 80 0.0003084 0.003688
389 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 3 80 0.0003084 0.003688
390 REGULATION OF MACROPHAGE CHEMOTAXIS 2 16 0.0003123 0.003707
391 POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 2 16 0.0003123 0.003707
392 NEGATIVE REGULATION OF CHEMOKINE PRODUCTION 2 16 0.0003123 0.003707
393 NEGATIVE REGULATION OF SECRETION 4 200 0.0003164 0.003746
394 REGULATION OF PROTEIN MATURATION 3 82 0.0003316 0.003917
395 NIK NF KAPPAB SIGNALING 3 83 0.0003437 0.004049
396 CYTOKINE METABOLIC PROCESS 2 17 0.0003535 0.004121
397 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 3 84 0.000356 0.004121
398 REGULATION OF IMMUNOGLOBULIN SECRETION 2 17 0.0003535 0.004121
399 CELL MOTILITY 7 835 0.0003557 0.004121
400 LOCALIZATION OF CELL 7 835 0.0003557 0.004121
401 NEGATIVE REGULATION OF GLUCOSE TRANSPORT 2 17 0.0003535 0.004121
402 NEGATIVE REGULATION OF LIPID STORAGE 2 17 0.0003535 0.004121
403 ESTABLISHMENT OF PROTEIN LOCALIZATION 9 1423 0.0003678 0.004246
404 TOLL LIKE RECEPTOR SIGNALING PATHWAY 3 85 0.0003686 0.004246
405 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 4 209 0.0003739 0.004295
406 REGULATION OF HETEROTYPIC CELL CELL ADHESION 2 18 0.0003973 0.004542
407 POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 2 18 0.0003973 0.004542
408 EPITHELIAL CELL PROLIFERATION 3 89 0.0004219 0.004812
409 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 10 1784 0.0004238 0.004821
410 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 4 217 0.0004309 0.004891
411 RESPONSE TO ESTROGEN 4 218 0.0004385 0.004964
412 POSITIVE REGULATION OF CATABOLIC PROCESS 5 395 0.0004409 0.004979
413 RESPONSE TO MUSCLE STRETCH 2 19 0.0004436 0.004998
414 REGULATION OF ICOSANOID SECRETION 2 20 0.0004924 0.005481
415 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 2 20 0.0004924 0.005481
416 REGULATION OF LYMPHOCYTE CHEMOTAXIS 2 20 0.0004924 0.005481
417 RESPONSE TO LIPOPROTEIN PARTICLE 2 20 0.0004924 0.005481
418 REGULATION OF MONOCYTE CHEMOTAXIS 2 20 0.0004924 0.005481
419 REGULATION OF LIPID TRANSPORT 3 95 0.0005108 0.005673
420 NEGATIVE REGULATION OF GENE EXPRESSION 9 1493 0.0005241 0.005792
421 REGULATION OF ORGANELLE ORGANIZATION 8 1178 0.0005231 0.005792
422 REGULATION OF INTERFERON GAMMA PRODUCTION 3 97 0.0005429 0.005952
423 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 2 21 0.0005437 0.005952
424 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 2 21 0.0005437 0.005952
425 NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS 2 21 0.0005437 0.005952
426 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 3 98 0.0005594 0.006096
427 RESPONSE TO VITAMIN 3 98 0.0005594 0.006096
428 NEGATIVE REGULATION OF CELL COMMUNICATION 8 1192 0.000566 0.006153
429 STRIATED MUSCLE CONTRACTION 3 99 0.0005763 0.00625
430 POSITIVE REGULATION OF ION TRANSPORT 4 236 0.0005911 0.006396
431 CELLULAR RESPONSE TO VIRUS 2 22 0.0005974 0.006405
432 POSITIVE REGULATION OF TRANSLATIONAL INITIATION 2 22 0.0005974 0.006405
433 REGULATION OF INTERLEUKIN 17 PRODUCTION 2 22 0.0005974 0.006405
434 REGULATION OF GLUCOSE TRANSPORT 3 100 0.0005934 0.006405
435 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 3 101 0.0006109 0.006535
436 REGULATION OF MUSCLE ORGAN DEVELOPMENT 3 103 0.0006468 0.006903
437 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 2 23 0.0006536 0.006912
438 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 2 23 0.0006536 0.006912
439 REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 2 23 0.0006536 0.006912
440 POSITIVE REGULATION OF STEROID METABOLIC PROCESS 2 23 0.0006536 0.006912
441 REGULATION OF FAT CELL DIFFERENTIATION 3 106 0.0007033 0.007403
442 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 3 106 0.0007033 0.007403
443 REGULATION OF MYELOID CELL APOPTOTIC PROCESS 2 24 0.0007123 0.007448
444 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 2 24 0.0007123 0.007448
445 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 2 24 0.0007123 0.007448
446 REGULATION OF AUTOPHAGY 4 249 0.0007225 0.007523
447 REGULATION OF T CELL DIFFERENTIATION 3 107 0.0007227 0.007523
448 CELLULAR EXTRAVASATION 2 25 0.0007734 0.008033
449 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 5 448 0.00078 0.008083
450 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 6 684 0.0007874 0.008142
451 LEUKOCYTE CELL CELL ADHESION 4 255 0.0007896 0.008147
452 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 6 689 0.0008179 0.00842
453 DEVELOPMENTAL PROGRAMMED CELL DEATH 2 26 0.000837 0.008579
454 REGULATION OF T HELPER CELL DIFFERENTIATION 2 26 0.000837 0.008579
455 NEGATIVE REGULATION OF TRANSPORT 5 458 0.0008613 0.008808
456 POSITIVE REGULATION OF ENDOCYTOSIS 3 114 0.0008687 0.008845
457 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 3 114 0.0008687 0.008845
458 REGULATION OF HORMONE SECRETION 4 262 0.0008734 0.008873
459 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 2 27 0.0009031 0.009017
460 REGULATION OF FATTY ACID TRANSPORT 2 27 0.0009031 0.009017
461 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 2 27 0.0009031 0.009017
462 INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 2 27 0.0009031 0.009017
463 CELLULAR RESPONSE TO ALCOHOL 3 115 0.000891 0.009017
464 LIPID STORAGE 2 27 0.0009031 0.009017
465 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 2 27 0.0009031 0.009017
466 REGULATION OF NEUTROPHIL CHEMOTAXIS 2 27 0.0009031 0.009017
467 PROTEIN SECRETION 3 116 0.0009136 0.009084
468 RESPONSE TO FIBROBLAST GROWTH FACTOR 3 116 0.0009136 0.009084
469 TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 3 118 0.00096 0.009524
470 NECROTIC CELL DEATH 2 28 0.0009715 0.009557
471 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 2 28 0.0009715 0.009557
472 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 2 28 0.0009715 0.009557
473 REGULATION OF MULTI ORGANISM PROCESS 5 470 0.000967 0.009557
474 POSITIVE REGULATION OF CELL DEVELOPMENT 5 472 0.0009855 0.009675
NumGOOverlapSizeP ValueAdj. P Value
1 MAP KINASE ACTIVITY 7 14 5.733e-17 5.326e-14
2 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 7 42 4.365e-13 2.028e-10
3 RECEPTOR SIGNALING PROTEIN ACTIVITY 9 172 6.735e-12 2.085e-09
4 PEPTIDASE REGULATOR ACTIVITY 9 214 4.795e-11 1.114e-08
5 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 7 92 1.339e-10 2.488e-08
6 PROTEIN KINASE ACTIVITY 12 640 1.996e-10 2.649e-08
7 PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 5 21 1.778e-10 2.649e-08
8 ADENYL NUCLEOTIDE BINDING 16 1514 3.643e-10 4.23e-08
9 KINASE ACTIVITY 12 842 4.497e-09 4.177e-07
10 PEPTIDASE ACTIVATOR ACTIVITY 5 38 4.301e-09 4.177e-07
11 RIBONUCLEOTIDE BINDING 16 1860 7.382e-09 6.234e-07
12 ENZYME REGULATOR ACTIVITY 12 959 1.923e-08 1.489e-06
13 PROTEIN SERINE THREONINE KINASE ACTIVITY 9 445 2.961e-08 1.965e-06
14 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 12 992 2.798e-08 1.965e-06
15 CYTOKINE ACTIVITY 7 219 5.752e-08 3.562e-06
16 MOLECULAR FUNCTION REGULATOR 12 1353 8.177e-07 4.747e-05
17 PEPTIDOGLYCAN BINDING 3 12 8.913e-07 4.871e-05
18 CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 4 56 2.123e-06 0.0001096
19 CYTOKINE RECEPTOR BINDING 6 271 4.77e-06 0.0002332
20 IDENTICAL PROTEIN BINDING 10 1209 1.614e-05 0.0007499
21 PROTEIN HOMODIMERIZATION ACTIVITY 8 722 1.728e-05 0.0007646
22 GLYCOSAMINOGLYCAN BINDING 5 205 2.025e-05 0.000855
23 CHEMOKINE ACTIVITY 3 48 6.729e-05 0.002718
24 ENZYME ACTIVATOR ACTIVITY 6 471 0.0001066 0.004127
25 CHEMOKINE RECEPTOR BINDING 3 57 0.0001127 0.004188
26 MAP KINASE KINASE ACTIVITY 2 12 0.0001725 0.006162
27 PEPTIDASE INHIBITOR ACTIVITY 4 177 0.0001985 0.006831
28 CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 2 15 0.0002735 0.009075
NumGOOverlapSizeP ValueAdj. P Value
1 INFLAMMASOME COMPLEX 6 12 1.144e-14 6.682e-12
2 CYTOSOLIC PART 8 223 2.301e-09 6.72e-07

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04621_NOD.like_receptor_signaling_pathway 33 59 4.11e-89 7.399e-87
2 hsa04620_Toll.like_receptor_signaling_pathway 14 102 2.406e-24 2.166e-22
3 hsa04380_Osteoclast_differentiation 12 128 8.824e-19 5.294e-17
4 hsa04622_RIG.I.like_receptor_signaling_pathway 10 71 1.424e-17 6.408e-16
5 hsa04010_MAPK_signaling_pathway 12 268 7.24e-15 2.606e-13
6 hsa04623_Cytosolic_DNA.sensing_pathway 8 56 2.949e-14 8.846e-13
7 hsa04660_T_cell_receptor_signaling_pathway 9 108 9.622e-14 2.474e-12
8 hsa04722_Neurotrophin_signaling_pathway 9 127 4.271e-13 9.609e-12
9 hsa04664_Fc_epsilon_RI_signaling_pathway 8 79 5.279e-13 1.056e-11
10 hsa04914_Progesterone.mediated_oocyte_maturation 8 87 1.172e-12 2.109e-11
11 hsa04920_Adipocytokine_signaling_pathway 7 68 1.523e-11 2.492e-10
12 hsa04210_Apoptosis 7 89 1.057e-10 1.585e-09
13 hsa04912_GnRH_signaling_pathway 7 101 2.602e-10 3.603e-09
14 hsa04062_Chemokine_signaling_pathway 7 189 2.09e-08 2.687e-07
15 hsa04014_Ras_signaling_pathway 7 236 9.587e-08 1.15e-06
16 hsa04510_Focal_adhesion 6 200 8.205e-07 9.23e-06
17 hsa04910_Insulin_signaling_pathway 5 138 2.955e-06 3.129e-05
18 hsa04662_B_cell_receptor_signaling_pathway 4 75 6.872e-06 6.864e-05
19 hsa04370_VEGF_signaling_pathway 4 76 7.246e-06 6.864e-05
20 hsa04012_ErbB_signaling_pathway 4 87 1.241e-05 0.0001117
21 hsa04151_PI3K_AKT_signaling_pathway 6 351 2.078e-05 0.0001781
22 hsa04141_Protein_processing_in_endoplasmic_reticulum 4 168 0.0001625 0.00133
23 hsa04640_Hematopoietic_cell_lineage 3 88 0.0004082 0.003194
24 hsa04670_Leukocyte_transendothelial_migration 3 117 0.0009366 0.007025
25 hsa04310_Wnt_signaling_pathway 3 151 0.00195 0.01404
26 hsa04612_Antigen_processing_and_presentation 2 78 0.007331 0.05075
27 hsa04350_TGF.beta_signaling_pathway 2 85 0.008653 0.05769
28 hsa04114_Oocyte_meiosis 2 114 0.01515 0.09742
29 hsa04650_Natural_killer_cell_mediated_cytotoxicity 2 136 0.02112 0.1311
30 hsa04120_Ubiquitin_mediated_proteolysis 2 139 0.022 0.132

lncRNA-mediated sponge

(Download full result)

Num lncRNA miRNAs           miRNAs count     Gene Sponge regulatory network lncRNA log2FC lncRNA pvalue Gene log2FC Gene pvalue lncRNA-gene Pearson correlation
1 RP13-514E23.1 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-450b-5p;hsa-miR-590-3p;hsa-miR-590-5p 11 MAPK10 Sponge network -2.158 0.0006 -1.396 0.00097 0.802
2 RP11-356I2.4 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-23b-3p;hsa-miR-330-3p 11 TNFAIP3 Sponge network -0.68 0.02565 -1.625 0 0.635
3 VIM-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-23b-3p;hsa-miR-26b-5p 11 TNFAIP3 Sponge network -1.424 0.00627 -1.625 0 0.534
4 C1orf132 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-450b-5p;hsa-miR-590-3p 10 MAPK10 Sponge network -1.519 0.00245 -1.396 0.00097 0.53
5 AC002480.5 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-26b-5p 12 TNFAIP3 Sponge network -2.128 0.02032 -1.625 0 0.466
6 AC002480.3 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p 11 TNFAIP3 Sponge network -1.522 0.03484 -1.625 0 0.449
7 PCED1B-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-429 10 TNFAIP3 Sponge network -0.575 0.17488 -1.625 0 0.436
8 LINC00473 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-330-3p 14 TNFAIP3 Sponge network -5.53 0 -1.625 0 0.428
9 RP11-166D19.1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 14 TNFAIP3 Sponge network -3.855 0 -1.625 0 0.417
10 LINC00861 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-330-3p;hsa-miR-429 10 TNFAIP3 Sponge network -1.254 0.02528 -1.625 0 0.402
11 LINC00565 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 10 TNFAIP3 Sponge network -1.493 0.05998 -1.625 0 0.388
12 HOTTIP hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p 11 MAPK10 Sponge network -1.941 0.00419 -1.396 0.00097 0.386
13 ZNF582-AS1 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-450b-5p;hsa-miR-590-5p 10 MAPK10 Sponge network -1.7 0.00019 -1.396 0.00097 0.38
14 PWAR6 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-450b-5p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 14 MAPK10 Sponge network -2.542 0 -1.396 0.00097 0.377
15 LINC00996 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p 10 TNFAIP3 Sponge network -1.208 0.03775 -1.625 0 0.371
16 GAS6-AS2 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-429 13 TNFAIP3 Sponge network -2.655 0 -1.625 0 0.359
17 MAGI2-AS3 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-429 13 TNFAIP3 Sponge network -2.414 0 -1.625 0 0.358
18

PART1

 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 13 MAPK10 Sponge network -3.06 7.0E-5 -1.396 0.00097 0.358
19 BZRAP1-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p 11 TNFAIP3 Sponge network -2.343 0 -1.625 0 0.354
20 BVES-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-429 13 TNFAIP3 Sponge network -4.161 1.0E-5 -1.625 0 0.349
21 FENDRR hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-450b-5p;hsa-miR-455-5p;hsa-miR-590-3p 11 MAPK10 Sponge network -4.793 0 -1.396 0.00097 0.348
22

LINC00702

 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p 13 TNFAIP3 Sponge network -2.704 0 -1.625 0 0.341
23 DNM3OS hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 14 TNFAIP3 Sponge network -2.298 1.0E-5 -1.625 0 0.336
24 RP11-20J15.3 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 11 TNFAIP3 Sponge network -5.104 8.0E-5 -1.625 0 0.336
25 RP11-401O9.4 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 12 TNFAIP3 Sponge network -0.359 0.78702 -1.625 0 0.332
26 SNHG14 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-450b-5p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 14 MAPK10 Sponge network -2.055 0 -1.396 0.00097 0.331
27 AP001055.6 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-27b-5p 11 TNFAIP3 Sponge network -1.091 0.00522 -1.625 0 0.324
28

MIR143HG

 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-330-3p;hsa-miR-429 15 TNFAIP3 Sponge network -4.237 0 -1.625 0 0.323
29 RP11-693J15.4 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 11 TNFAIP3 Sponge network -3.319 0.00281 -1.625 0 0.32
30 RP11-81H14.2 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-330-3p;hsa-miR-429 15 TNFAIP3 Sponge network -2.322 0.00014 -1.625 0 0.313
31 RP11-399O19.9 hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 10 TNFAIP3 Sponge network -0.911 0.02612 -1.625 0 0.309
32 RP11-426C22.4 hsa-let-7a-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 10 TNFAIP3 Sponge network -0.045 0.93351 -1.625 0 0.308
33 RASSF8-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-141-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 11 TNFAIP3 Sponge network -0.877 0.00508 -1.625 0 0.307
34 WDFY3-AS2 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-455-5p;hsa-miR-590-3p;hsa-miR-590-5p 12 MAPK10 Sponge network -1.607 0 -1.396 0.00097 0.307
35 LINC01088 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p 11 MAPK10 Sponge network -1.887 0.00269 -1.396 0.00097 0.292
36 RP11-175K6.1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p 11 TNFAIP3 Sponge network -2.386 0 -1.625 0 0.289
37 RP11-867G23.10 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-19b-3p;hsa-miR-26b-5p 10 TNFAIP3 Sponge network -5.684 0 -1.625 0 0.288
38 RP11-359E10.1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-23b-3p;hsa-miR-26b-5p 11 TNFAIP3 Sponge network -1.216 0.0438 -1.625 0 0.28
39 HAND2-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 14 TNFAIP3 Sponge network -5.605 0 -1.625 0 0.279
40 LINC00840 hsa-miR-130a-3p;hsa-miR-130b-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-590-3p 10 MAPK10 Sponge network -1.001 0.27483 -1.396 0.00097 0.27
41 RP11-1134I14.8 hsa-miR-130a-3p;hsa-miR-146b-5p;hsa-miR-193a-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-455-5p;hsa-miR-590-3p 10 MAPK10 Sponge network -0.743 0.25713 -1.396 0.00097 0.261
42 EMX2OS hsa-miR-130a-3p;hsa-miR-146b-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-221-3p;hsa-miR-222-3p;hsa-miR-29a-3p;hsa-miR-454-3p;hsa-miR-455-5p;hsa-miR-590-3p 10 MAPK10 Sponge network -2.206 0.03389 -1.396 0.00097 0.259
43 RP11-326C3.11 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-27b-5p;hsa-miR-330-3p 13 TNFAIP3 Sponge network -1.196 3.0E-5 -1.625 0 0.255
44 TBX5-AS1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p 13 TNFAIP3 Sponge network -2.557 2.0E-5 -1.625 0 0.254
45 RP11-25K19.1 hsa-let-7a-5p;hsa-let-7b-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-125a-5p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-330-3p;hsa-miR-429 12 TNFAIP3 Sponge network -1.478 0.00829 -1.625 0 0.252
46 CTD-2013N24.2 hsa-let-7a-5p;hsa-let-7d-5p;hsa-let-7e-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-107;hsa-miR-125a-5p;hsa-miR-141-3p;hsa-miR-19a-3p;hsa-miR-19b-3p;hsa-miR-26b-5p;hsa-miR-429 12 TNFAIP3 Sponge network -1.002 1.0E-5 -1.625 0 0.251

Quest ID: 21817f19f410ee933f0d5ab929a2ccbc